Qing Wu

Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1‐driven leukemia/lymphomas

J. Cowell, H. Qin, M. Ren, 2017, International journal of cancer.

Targeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models

S. Malek, J. Karp, J. Cowell, 2016, Oncotarget.

FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome

J. Cowell, H. Qin, Jan van Riggelen, 2018, Leukemia.

Development of ZMYM2‐FGFR1 driven AML in human CD34+ cells in immunocompromised mice

T. George, J. Cowell, H. Qin, 2016, International journal of cancer.

FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model

J. Cowell, H. Qin, M. Ren, 2016, Haematologica.